Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Rotavirus Vaccines
Investigators at Erasmus University, Institute for Medical Technology Assessment have published new data on rotavirus vaccines
April 2nd, 2008
Data detailed in 'The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the Netherlands' have been presented. "The objective of this study was to estimate the cost-utility of mass vaccination of 0-4-year-old children with Rotarix in the Netherlands. We used a Markov process with Dutch data on incidence, resource use and costs (GP, hospitalisation, productivity loss and household costs) to compare vaccination to conventional treatment from a societal perspective," scientists writing in the journal Vaccine report. "Utility loss due to rotavirus-induced diarrhoea was measured using EQ5D, with GPs and paediatricians serving as proxies to fill out the...
Source: Vaccine Weekly (2008-04-02)
|
